Cost-effectiveness analysis of replacing the 10-valent pneumococcal conjugate vaccine (PCV10) with the 13-valent pneumococcal conjugate vaccine (PCV13) in Brazil infants

.

Source: Human Vaccines and Immunotherapeutics - September 22, 2020 Category: Allergy & Immunology Authors: Johnna Perdrizet Carlos Felipe S. Santana Thais Senna Rodrigo Fernandes Alexandre Rodrigo Sini de Almeida Julia Spinardi Matt Wasserman Source Type: research